cvi42 Auto Imaging vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Circle Cardiovascular Imaging
VS
by iHealthScreen

AI Verdict

Tool A (cvi42 Auto Imaging) focuses on comprehensive AI-powered analysis of cardiovascular MR and CT images for diagnosis, plaque quantification, and workflow streamlining. Tool B (iPredict Eye Screening) is an AI-powered screening tool for retinal diseases like AMD, DR, and Glaucoma, and also provides risk prediction for systemic diseases like stroke and heart attack using retinal images. While both utilize AI for medical imaging analysis and touch upon cardiovascular health, their primary imaging modalities and specific diagnostic/screening applications are distinct, making them adjacent rather than direct competitors.

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if your cardiology or radiology department requires a comprehensive, AI-powered solution for in-depth analysis of cardiovascular MR and CT images. It excels in quantitative analysis of cardiac function, flow, tissue characterization, and plaque assessment, offering detailed 3D visualization and streamlined reporting for complex cardiovascular conditions. This tool is particularly well-suited for institutions prioritizing on-premise data processing and control, ensuring patient privacy and compliance with strict IT policies.

View cvi42 Auto Imaging →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if your primary care clinic, ophthalmology practice, or telemedicine service needs an efficient, AI-driven screening tool for early detection of common retinal diseases like age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma. It provides rapid, automated reports within minutes, making it ideal for high-throughput screening in diverse clinical settings and for identifying patients who require referral to an ophthalmologist.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cvi42 Auto Imaging iPredict Eye Screening
Pricing Contact for pricing Contact for pricing
Deployment On-premise, Stand-alone, Networked environment. Cloud compatibility is mentioned as a feature, but recent FDA clearances for modules like cvi42 | Plaque emphasize on-premise deployment for data control. Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iPredict Eye Screening

iPredict Eye Screening emphasizes ease of use with a non-invasive, fast test (under 5 minutes) and rapid report generation (under 60 seconds), making it highly accessible for primary care settings and telemedicine. cvi42 Auto Imaging, while offering automated features, is a more complex diagnostic tool for cardiovascular imaging, implying a steeper learning curve for specialized professionals.

Clinical Value

cvi42 Auto Imaging

cvi42 Auto Imaging offers comprehensive analysis of cardiovascular MR and CT images, including advanced features like plaque quantification and multi-modality support, providing a holistic view for complex cardiac conditions. iPredict Eye Screening focuses on screening for specific eye diseases and systemic disease risk, which is valuable for early detection but less comprehensive in its diagnostic depth compared to cvi42's detailed imaging analysis.

Pricing & Value

Tie

Both tools require contacting the company for specific pricing, making a direct comparison difficult. iPredict Eye Screening provides an estimated per-patient cost, which offers some transparency for a SaaS model. cvi42 Auto Imaging's pricing is noted as complex due to licensing and modularity, with estimates for perpetual licenses and annual maintenance fees, suggesting a higher initial investment.

Enterprise Readiness

cvi42 Auto Imaging

cvi42 Auto Imaging is designed for integration into hospital and networked environments, with features like DICOM connectivity to PACS and HL7 compatibility, centralized user management, and advanced enterprise security. Its on-premise deployment options also cater to strict hospital IT policies and data protection. iPredict Eye Screening is cloud-based and integrates with EHR and telemedicine, but the detailed enterprise-level integration features are less explicitly stated compared to cvi42.

Innovation

cvi42 Auto Imaging

cvi42 Auto Imaging demonstrates strong innovation with its unified platform for cardiac MR and CT, including AI-enabled plaque and PCAT analysis (for research use), and advanced vascular CT capabilities. iPredict Eye Screening is innovative in its AI-powered screening for multiple eye diseases and systemic risk prediction, but cvi42's breadth of advanced imaging analysis across different modalities for complex cardiovascular conditions gives it an edge in innovation.

Support & Docs

cvi42 Auto Imaging

Circle Cardiovascular Imaging highlights its commitment to world-class solutions and support, with industry-leading customer satisfaction scores and readily available documentation and tutorials for cvi42. While iHealthScreen focuses on the ease of operation of iPredict, specific details about their support infrastructure and comprehensive documentation are not as extensively detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cvi42 Auto Imaging iPredict Eye Screening
Name cvi42 Auto Imaging iPredict Eye Screening
Company Circle Cardiovascular Imaging iHealthScreen
Description AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows. FDA-cleared AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services.
Primary Specialties Cardiology, Radiology, Vascular Surgery Family Medicine, Internal Medicine, Ophthalmology
Key Features (partial list) AI-enabled automated contouring and segmentation, Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment) AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma, Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service

Videos

Demos, reviews, and walkthroughs featuring cvi42 Auto Imaging and iPredict Eye Screening.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cvi42 Auto Imaging offers simplified and smart reporting with infographics and CAD-RADS classification, which can be integrated into clinical workflows. iPredict Eye Screening, on the other hand, explicitly offers Electronic Health Record (EHR) Solutions and AI-Based Telemedicine Service, suggesting a more direct and potentially deeper integration for streamlined patient data management and remote care.
cvi42 Auto Imaging provides AI-enabled automated contouring and segmentation for cardiovascular MR and CT images, aiding in precise diagnosis and quantitative analysis. iPredict Eye Screening boasts high accuracy, approximately 95% on average, with specific figures for AMD sensitivity at 86.86% and specificity at 94.13% for the detection of diabetic retinopathy, age-related macular degeneration, and glaucoma.
cvi42 Auto Imaging is designed for cardiologists, radiologists, and vascular surgeons, focusing on comprehensive analysis of cardiovascular MR and CT images to enhance diagnostic precision and streamline cardiac imaging workflows. iPredict Eye Screening is tailored for ophthalmologists, family medicine, and internal medicine, providing rapid AI-powered screening for retinal diseases and risk prediction for systemic conditions, fitting into a primary care or ophthalmology screening workflow.
While cvi42 Auto Imaging emphasizes simplified reporting and automated features, the learning curve would likely involve understanding its comprehensive cardiovascular imaging analysis capabilities. iPredict Eye Screening highlights its ease of operation, non-invasive nature, and advanced touchscreen interface, suggesting a potentially quicker learning curve for its screening functions.
cvi42 Auto Imaging's privacy policy outlines data protection measures, with data stored in Canada and potential use of cloud providers in the USA. For on-premise solutions, data control remains with the clinician. iPredict Eye Screening, being cloud-based, would rely on the security protocols of its Software as a Medical Device (SaMD) platform, though specific additional security measures beyond HIPAA are not detailed in the provided information.
The provided information does not explicitly detail audit trail features for either cvi42 Auto Imaging or iPredict Eye Screening. However, robust medical imaging and screening software typically include such functionalities to ensure data integrity and accountability in clinical settings.
cvi42 Auto Imaging aims to enhance healthcare outcomes by unlocking data insights and empowering efficient decision-making, suggesting time savings through streamlined workflows and precise diagnosis. iPredict Eye Screening offers fast results, with tests completed in less than 5 minutes and reports in under 60 seconds, which can lead to significant time savings in screening processes and potentially earlier intervention for patients.
AI Tool Finder
AI-powered search. Results may not be comprehensive.